Discovery of TAK-659 an orally available investigational inhibitor of Spleen Tyrosine Kinase (SYK)Betty Lam, Zhe Nie, Yasuyoshi Arikawa et al.|Bioorganic & Medicinal Chemistry Letters|2016Cited by 62
Biological Characterization of TAK-901, an Investigational, Novel, Multitargeted Aurora B Kinase InhibitorPamela Farrell, Ron de Jong, Lihong Shi et al.|Molecular Cancer Therapeutics|2013Cited by 46
Supplementary Figure Legends from Biological Characterization of TAK-901, an Investigational, Novel, Multitargeted Aurora B Kinase InhibitorPamela Farrell, Ron de Jong, Lilly Zhang et al.|Unknown|2023Cited by 0
Supplementary Figure 2 from Biological Characterization of TAK-901, an Investigational, Novel, Multitargeted Aurora B Kinase InhibitorPamela Farrell, Ron de Jong, Lihong Shi et al.|Unknown|2023Cited by 0
Supplementary Figure Legends from Biological Characterization of TAK-901, an Investigational, Novel, Multitargeted Aurora B Kinase InhibitorPamela Farrell, Ron de Jong, Lihong Shi et al.|Unknown|2023Cited by 0